source
- STAT+: Michigan Supreme Court ruling allows probe into Lilly insulin pricingLilly was accused of charging “grossly” excessive prices for different insulin products that forced some patients to ration or forego the drug.STAT · 12m ago↗ source
- Novo Nordisk's heart drug ziltivekimab fails Phase 3 trial, raising doubts on inflammation-targeted therapiesNovo Nordisk announced that its experimental cardiovascular drug ziltivekimab did not meet the primary endpoint in a Phase 3 study. The trial was designed to see if the drug could lower the inciden…